Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Accredo Expands Hemophilia Business With Purchase Of Pediatric Services of America

This article was originally published in The Pink Sheet Daily

Executive Summary

Following Medco's acquisition of Accredo, the specialty pharmacy itself enters into a $72 mil. deal to buy "selected assets" of Pediatric Services of America.

You may also be interested in...



Express Scripts Makes Specialty Pharmacy Portfolio A Priority Through Acquisition

Combination of CuraScript and Priority Healthcare will have sales of over $3 bil. Acquisition will provide CuraScript with access to new therapies, including those in fertility, hemophilia, home infusion, pulmonary hypertension and pulmonary fibrosis.

Medco Creates Largest U.S. Specialty Pharmacy Through Accredo Acquisition

The companies' combined specialty drug sales were about $4.3 bil. in 2004. The acquisition puts Medco in a position to take a large share of Medicare Part B drug business in addition to its stake in the Part D outpatient drug benefit.

NEJM, JAMA Editorials Give Opposing Opinions Of Mandatory HPV Vaccination

Two of the leading medical journals are offering opposing viewpoints on mandatory human papilloma virus vaccination, with experts contributing perspective pieces that directly reflect the larger political and social division over the issue

Topics

UsernamePublicRestriction

Register

PS061069

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel